T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0030
0.00 (0.00%)
Apr 30, 2026, 9:59 AM EST
T2 Biosystems Market Cap
T2 Biosystems has a market cap or net worth of $84.14 thousand as of April 30, 2026. Its market cap has decreased by -97.60% in one year.
Market Cap
84.14K
Enterprise Value
16.95M
Revenue
7.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 7, 2014, T2 Biosystems's market cap has decreased from 274.87M to 84.14K, a decrease of -99.97%. That is a compound annual growth rate of -49.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 84.14K | -40.00% |
| Dec 31, 2025 | 140.23K | -98.41% |
| Dec 31, 2024 | 8.84M | -65.23% |
| Dec 29, 2023 | 25.42M | 144.54% |
| Dec 30, 2022 | 10.39M | -87.87% |
| Dec 31, 2021 | 85.67M | -53.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hypha Labs | 3.78M |
| Centogene | 3.58M |
| InVitro International | 1.97M |
| ProPhase Labs | 1.33M |
| IDenta | 707.98K |
| NovelStem International | 483.46K |
| Medical Imaging | 63.82K |
| CardioGenics Holdings | 14.29K |